4 monahans
Part of the SUMER
'Group
MUSGROVE LEUKAEMIC GROUP SOMERSET
Raising funds for the benefit of Patients in Somerset
UNAUDITED FINANCIAL STATEMEIYTS
FOR THE YEAR ENDED 28 FEBRUARY 2025
REGISTERED CHAIUTY NUMBER 1036580

MUSGROVE LEUKAEMIC GROUP SOMERSEI T
Raising funds for the benefit of Patients in Somerset
TRUSTEES ANNUAL RKPORT FOR THE YEAR NDID 28 Fll4 BRUARY 2025
I FLRENCL AND ADIIqINISTRATION DETAILS
Charity name..
Registered Charity number:
Charity's principal address:
Musgrove Leukaen]ic Group Somerset
1036580
16 Durleigh Road
BRIDGWATER
Somerset
TA6 7FIR
Trustees:
Mrs Patricia Reed (Chairperson)
Miss Jane Allin (Secretary)
Mrs Maureen Hudson
Mrs Margaret Smith
Mr Bernard Reed (Treasurer)
Mrs Pat Cornish
Mr David Edwards
Professional Adviso
Bankers:
National Westminster Bank plc
26127 Fore Street
TAUNTON
Somerset
Independent Examiner:
Monahans
Chartered Accountants
th
6 Floor
Ihitefriars
Lewins Mead
BRISTOL
BSI 2NT
STRUCTURE GOVERNANCE AND MANAGLMEI NT
Musgrove Leukaemic Group Somerset is a registered charity and has been constituted as an
unincorporated association govei'ned by a formal constitLition, A copy of the constitution may be
obtained on application to the Secretary.
Trustees are elected at each Annual General Meeting biit retiring Trustees are eligible for re-
election. The Officers may hold office until retirement or by rernoval at an Annual General
Meeting.
Co-opted Trustees nyay be appointed by the Commiltee at any time and generally have special
l(nowledge or experience with leukaemia or related conditions. They may serve for such period as
decided by the Committee or by their retirement,

MUSGROVE LEUKAEMIC GROUP SOMERSE4 T
Raising funds for the benefit of Patients in Somerset
TRUSTEES AIYNUAL REPORT FOR THL YEAR ENDED 28 FKBRUARY 2025
(continued)
OBJECTIVES AND ACTIVITIE< S
The Charity's Objectives and aclivttiesfor the Public Benefit
The objects of the Group are to relieve persons suffering from Leukaemia and associated conditions
by assisting and funding the treatments and welfare of such pe￿OnS at Musgrove Park Hospital,
Taunton Somerset or any other area authorised by the medical staff.
The Group carries out these objects by:
Sponsoring the medical staff that are considered key by the Somerset NHS Foundation Trust to
maintaining Musgrove Parlc Hospital as a centre for the treatment of Leukaemia and other related
diseases.
The grants made to nursing staff for training are in an aspect which when complcted will enhance
the experience of Leulcaemia patients whilst receiving treatment 'for Leukaemia and other related
diseases.
The purchasc of cquipment and furniture is n￿de following recommendations from the medical
staff with a view to improving the quality of the treatment and the emotional and physical well-
being of both suffers and relatives.
Churtsy Organisatlon dnd Hlstory
The Musgrove Leukaemic Group Somerset was launched in 1978 and is run completely by unpaid
volunteers who absorb all their own personal expenses. There are no paid Officers and overheads
are kept to an absolute minimum thercby cnsuring tbat most of the funds raised goes to the
Haematology Unit at Musgrove Park Hospital, Taunton. The hospital has become a major centre in
the South West for the diagnosis and treatment of leukaemia and related blood disorders.
In general the aims of the Group are as follows:
To maintain Musgrove Park 14ospital as a major centre for the diagnosis and treatsnent of
l¢ukaemia and related blood disorders by the most up-to-date techniques,
ii)
To keep the public inforn]ed on progress being made on the diagnosis and treatment of these
diseases.
The Group meets regularly in Bridgwater and Taunton.

MUSGROVE LEUKAEMIC GROUP SOMERSET
Raising funds for the benefit of Patients in Somerset
TRUSTE￿1 S ANNUAL REPORT FOR T￿{ YEAR ENDED 28 FEBRUARY 2025
(continued)
Policy is discussed at both Group and Committee meetings, but the Cornmittee has the duty to
manage the Group and the power to ultimately make executive decisions.
The Group has area representatives covering Somerset at Bridgwater, Burnham on Sea, Chard and
Ilminster, Minchcad, Taunton, and Wellington. The area representatives act as local contacts
organising events and visiting various businesses, people or other organisations as required. In turn
they report back to Group meetings on a regular basis,
ACHIEV￿1 MENTS AND PERFORMANC
Chairperson's Report
I reported last year that an ambulatory room had been established in Ward 9 and the Group were
funding various pieces of equipment, The facility has prov¢d very successful and additional CADD
pumps, a bladder and cardiac monitors have been purchased.
The NHS Trust are refurbishing Ward 9, so temporarily the unit has been movcd to Parkside.
Ivhilst the alterations are being carried out the conversion of the bathroom to a shower room that
the MLGS ag￿ed to fund should be completed.
Financial pressure can be a burden for some patients and the Group has established a FIardship fund
to which patients can apply for assistance through the nursing team.
l-he Musgrove Leukaemic Group continuc to sponsor a pool car to enable th¢ hematology iiurses to
provide chemothernpy to patients in Brtdgwater and Wellington hospAtals, In the prior year, two
ycars, worth of expense was paid in advance.
The appointment of Icelly Savva as a reflexologist on Ward 9 has been well received by the
patients. The sponsorship of that post and the partial salary support of the nurse practitioner are
ongoing projects that the Group support.
Fimds are held to support these projects and any other project that falls within our constitution to
enable the Taunton and Somerset NHS Foundation Trust to meet the needs of the patients.
I would like to th￿Ik the officers and committee members for their continued commitment.
Tricia Reed
Chairperson

IVIUSGROVE LEUKAII MIC GROUP SOMEI RSET
Raising funds for the benefit of PY4tients in So]nerset
TRUSTEES ANNUAL REPORT VOR THK YEI AR ENDED 28 FEBRUARY 2025
(continued)
ConsulÉanÉ s Report
Welcome to all and I am pleased to report that the MLGS continues lo strengthen. While the NHS is
always under pressure often asked to deliver more than is realistically capable of, it is reassuring to
know that the people of Somerset and former patients continue to support our endeavours to help
deliver the best possible service for our haemato-oncology patients. The patient feedback surveys
report excellent high standards which the department is very proud of.
Since last year the department has seen stable staffing levels and been able to keep up with the
demands of the ever increasing service. I am very grateful to the all the staff- doctors, nurses and
allied health professionals- for their on-going commitments. This has been aided in significant part
to the generosity of the MLGS.
The revolution in haematology and cancer drngs shows no sign of abating with ongoing less toxic
trcatments continuing to be developed and made available on the NHS. Terminal diagnoses have
now in many C￿eS become chronic long-lived conditions or highly curable. Patients who were too
'unfit' for the toxic treatments now have options to improve longevity and quality of life.
The MLGS continues to be financially very secure and able to offer many improvements to assist in
patient care:
Further ￿furbi8l]me￿t of the Day Unit with new reclining chairs has continued.
Thc ambulatory care unit is now fully operational - a long time in gestation requiring
significant convincing of the trust management- providing paticnts a chancc to reduce
inpatient stays. We are proud to have helped refurbish the unit and provide equipment for
this.
The most successful innovation is the development of the hardship fund - available to all
our patients who would receive grants to bc cligiblc for funds to use for travel for
appointments for treatment or travel to their transplant centre. This considerably reduced the
stress for paticiit who struggle financially and due to illness are not able to go back to work,
Your generosity has enabled a reflexologist to attend Ward 9 weekly and provide
complimentary therapy to patients
The conve￿10n of the old bathroom on Ward 9 has provided a wet room and toilet
As part of our exoiting new project regarding prehabilitation of patients with acute
leukaemia we have been able to purcbase ￿7p measure to allow fitness assessment,
I once again am overwhelmed by the generosity of the local population with all the donations as
well as the time and eft'ort of fund raising. The department remains indebted to have the support of
the MLGS and we will continue to treat our patients with the best care and dignily available.
Deepak Mannari
Consultant Haematology 16 May 2025.

I￿[usGROVE LKUKAElVItC CROUP SOMKRSET
Raising fullds for the benefit of Patients in Somerset
TRUSTEES ANNUAL REPORT FOR THE YEAR ENDED 28 FEBRUARY 2025
(continued)
FINANCIAL REVIEW
Treasurers Reporl
th
The total raised for the year ended 28 February 2025 amounted to £54,609.
th
The total expenditure for the year ended 28 Febnwy 2025 is £95,196.
The total raised since fonnation as at the 28th of Febnw 2025 is £4,131,806.
The year ending FebrLLqry 2025 has seen a level of fundraising that reflects the Groups limited
ability to generate funds. Unfortunately, this will become the norm going forward, therefore the
continued support of our regular contributors, donors, and friends plus the dedlcated work of the
Trnstees and Members is essential to enabIe the Group to continue to support projects at Musgrove
Park Hospital.
The Trustees, m¢mbers and volunteers absorb all their own expenses, so overheads are Minim￿ and
are currently under l % of fLmds Taised.
The Musgrove Lcukaemic Group Somerset is in a sound financial position because of the retained
funds held.
Detailed accounts are attached for inspection.

MUSGROVK L￿4 UIL4EMIC GROUP SOMERSKT
Raising funds for the beiiefit of Patiellts in Somerset
TRusTE￿s ANNUAL REPORT FOR THE YEI AR ENDE4 D 28 FfBRUARY 2025
(continued)
Reserves Policy
Musgrove Leukaemic Group Somerset (MLGS) retains ￿serVeS, and this document explains our
policy.
In defining this policy the Trustees have considered..
l) Income forecasts for future ye￿5 taking into account the reliability of each source of llicome and
the potential for securing new income from alternative sources.
2) Expenditure forecasts for fLrture years.
3) The need to bold reserves should a medical breakthrough neccssitatc the urgent purchase of n¢w
equipment.
4) The need to hold reserves to meet our immediate commitments should income levels drnsticdly
fall.
The Group attempts to maintain reserves of approximately £200,000, which is represented by cash
on short-term dcposit and ill thc Group bank accounts. The present level of retained funds results
from several legacies received in the financial year ending 2022, it is not the trustees intention to
hold these funds as reserves.
The Group believes it is prndent to keep this level of surpIus to:
l) Ensure the Group can maintain its commitment to fund research salaries and consumablcs
for year periods and to be able to so even if income levels should substantially 'fall for a
period sufficient to allow alternativ¢ arnngcmcllts to be made.
2) To provide equipment on urgent request if the need should arise.
3) To act as a buffer against any unforeseen eventuality.
Our levels of reserves are constantly monitored and reviewed both at Group meetings and
Comrnittee meetings.
The present level of Reserves is considered appropriate to enable the Group to meet our
commitments for the financial year elldillg 2026. The legacies received in 2022 has resulted in the
Musgrove Leukaemic Oroup Somerset being in a strong financial position.
Bern￿rd Reed
Hon. Treasurer.

MUSGROVE LEUKAEMIC GROUP SOMEI RSET
Raising tunds for the benefit of Patients in Somerset
TRUSTEES AI¥I¥UAL Rf4 PORT FOR THE YEAR ENDED 28 FEBRUARY 2025
(Continued)
Trustees, anllual report
The Musgrove Leukaemic Group Somerset (MLGS) was fomied in April 1978 by parents whose
children wwe undergoing treatment for leukaemia. Due to the limited facilities at Musgrove Park
Hospital they had to visit hospitals in Southampton and Bristol for treatment, placing severe strain
on the families,
The present Trustees are a group of people continuing to fLU]draise to improve the facilities for
leukaemia and lymphoma patients and their families in Somerset.
The funds raised by the MLGS are utilised to purchases equipment for the wards to improve the
experience of patients whilst undergoing treatmcnt.
The MLGS has now raised over £4 Million, 95 % of which has/is being made available to Musgrove
Park Hospitals, Haematologyloncology and Children's Unit becausc all the TTUSte¢s and members
services are voluntary.
The Trustees will work with the medical team to provide facilities to improve the patient experience
whilst they arc re￿IVing treatment.
The funds are raised by various means but principally from donations including legacics,
collections, and other fundraising evcnts.
Our aim is to contillue to raise funds to improve the hospital experience for leukaemia and
lymphoma patients.

MUSGROVE LEUKAEMIC GROUP SOMERSEI T
Raising funds for the benefit of Patients in Somerset
TRUSTKES ANNUAL REPORT FOR TH￿1 YEAR ENDED 28 FEBRUIIRY 2025
(continued)
STATEIVIENT OF TRUSTfES RLSPONSIBILITIES
Cbarity law requires the trust¢es to prepare financial statements for each financial year which show
a true and fair view of the state of affairs of the charity and its financial activities for that period. In
preparing those financial statements, the trustees are required to
Select suitable accounting policies and then apply thern consistently"
Make judg¢ments and estimates that are reasonable and prudent.
stste whether applicable accounting standards and statements of recommended practice
have been followed, subject to ally departure disclosed and explained in the financial
statements, and
Prepare the financial statements on the going concern basis unless it is inappropriate to
presume that the charity will continue in operational existence.
The Trustees are responsible for keeping proper accounting records whAch disclose with reasonable
accuracy at any tin)c the financial position of the charity and to enable them to ensure that the
financial statements comply with the Charities Act 2011.
They are also responsible for
safeguarding the assets of the charity and hence for taking reasonable steps for the prevention and
detection of fraud and other irregularities.
DECLARATION
The Trustees declare that they have approved the Trnstees, Report.
Signed on behalf of the charity's trustees,,
Tricia Reed
Chair

IvtUSGROVE LLUKAKMIC GROUP SOMERSET
Raising funds for the benefit of l>atients in Somerset
Independent Examiner's Report to tbe Trustees of Musgrove Leukaemic Group Somerset
I report on the accounts of Musgrove Leukaemic Group Somerset for the year ended 28 February
2025 which are set out on pages 9 to 13.
Respective responsibilities of trnstees and examiner
The charity's trustees are responsible for the preparation of the accounts. The charity's trustees
consider that an audit is not required for this year under section 144 of the Clmrities Act 2011 (the
Charities Act) and that an independent examination is needed,
It is my responsibility to:
examine the accounts under section 145 of the Charities Act.
to follow the procedures laid down in the general Directions given by the Charity
Commissioncrs (under section 145 (5) (b) of the Charities Act). and
to state whether particular matters have come to my attention.
Basis of independent examiner's report
My examination was carricd out in accordanc¢ with the generaI Directions given by the Charity
Commission. An exarnination includes a review of the accounting records kept by th6 charity and a
comparison of the accounts presented with those records. It also includes consideration of any
unusual items or disclosures in the accounts and sccking explanations from you as trustees
concerning any such matters. The procedures undertaken do not provide all the evidence that would
be required in all audit, and consequently no opinion is given as to whether the accounts present a
'ITue and .fair' view and the report is limited to those Matte￿ set out in the statement bclow.
Independent exa]niner's statement
In connection with my exatnination, no matter has come to my attention:
i)
which gives tlle reasonable cause to believe that in, any material respect, the requirements
to keep accounting records in accordance with section 130 of the Charities Act; and
to prepare accounts which accord with the accounting records and comply with the
accounting requirements ot. the Chariti¢s Act have not bccn mc: or
2)
to wljich, in my opinion, attention should be drawn in order to enable & proper
understanding of the accouiits to be reached.
Mark Powell
Moiiahans
6 ' Floor
Whilefriars
Lewins Mead
Bristol
BSI 2NT
Date:

IIIUSGROVE LLUKAEMIC CROUP SOMERSET
Raising fullds for the benefit of Patients in Somerset
STATEMENT OF FINANCIAL ACTIVITIES
FOR THE YEI AR ENDED 28 F￿BRUARy 2025
Unrestricted Restricted Total Funds Total Funds
Funds
Funds
2025
2024
INCOME & EXPENDITURE
Inco]nillg Ilesources
Donations, legacies and similar incoming resources;
Donations
Fund Raising
Collections
Covenants & Gift Aid
(including tax recovered)
12,043
6,355
1,142
12,043
6,355
1,142
10,671
8,242
1,558
1,920
1,920
2,405
Investment Income:
Bank Interest
33,149
33,149
24,938
TOTAL INCOMING RESOURCES
54,609
54,609
47,814
Resources xpended
Note
Direct Charitable Expenditure
Fund Raising and Publicity
Management alld
Administration
93,425
681
93,425
681
24,743
209
1,090
1,090
986
TOTAL RESOURCES EXPENDED
95,196
95,196
25,938
NET (OUT)/INFLOW OF
RESOURCES FOR THE YEAR
AND MOVEMENT IN FUNDS
(40,587)
(40,587)
21,876
Balance brought forward at
l March 2024
911,269
911,269
889,393
BALANCES CARRIED FORWARD
AT 28 FEBRUARY 2025
870,682
870,682
911,269
10

MUSGROVE LLUKALMIC GROUP SOMERSET
Raising funds for the benefit of Patients in Somerset
BALANCE SHE￿1 T
AS AT 28 ￿￿BRUARy 2025
2025
2024
Note
CURRENT ASSETS
Debtors
Short term deposits
Cash at bank and in hand
623
800,000
114,174
722
750,000
160,967
914,797
911,689
CREDITORS: Amounts falling due within one year
44,115
420
TOTAL IYET ASSETS
870,682
911,269
Funded by:
UNR￿1 STRICTED FUNDS
Gencral Fund
870,682
911,269
These accoimts approved by the Tn￿eS on.
./1,.
ernard Reed
Treasurer
For and on behalf of tbe Trustees
Jane Allin
Secretary
11

MUSGROVEI LEUKAEMIC GROUP SOMEI RS[I T
Raising funds lor the benefit of Patiellts ill Somerset
NOTES TO THE ACCOUNTS
FOR THE YEAR ENDKD 28 FEBRUARY 2025
ACCOUNTING POLICIES
Accounting basis and standards
The financial statements have been prepared under tbe historical cost convention and
in accordance with applicable accounting standards, the Charities SORP (FRS102)
(Accounting and Reporting by Ch￿￿tleS) and comply with the Charities (Accounts
and Reports) Regulations 2008 issued under the Charities Act 2011.
Voluntary Income
Voluntary income is received from a numbcr of sources, including donations,
collections and other fund raising events. Such income is included in full in the
income and expenditure account wh¢n received.
Restricted and Unrestricted Fllnds
Where appropriate, the accounts distingllish between restrACted and unrestricted
funds. The fonner are received from dollo￿ and are subject to restrictions on the
purpose for which they may be used. U]]restiicted funds are thos¢ where there are
no externally imposed restrictions which the charity may use at its discretion to
achieve its objectives.
In the opinion of the Officws the Charity does not operate any restricted funds.
d)
Short Term Deposits
Short term deposits represent monies placed on deposit with National Westminstcr
Bank T￿asury Reserve Centre.
Bank Interest
Bank Interest is credited to the incorne and expenditure account when received.
Covenants
Covenants are credited to the income and expenditure account when received.
Provision is made foi, recoverable income tax arising from the covenants.
12

IkWSGROVE LEUKAEMIC GROUP SOMKRSKT
Raising funds for the benefit of Patlents in Somerset
NOTES TO THE ACCOUNTS
FOR THEI YEAR NDKD 28 FEBRUARY 2025
(Continued)
Taxation
Musgrove Leukaemic Group Somerset is a registered Charity and the results of its
normal activities are not liable to co￿oration tax.
Unrestricted Restricted Total Funds Total Funds
Funds
Funds
2025
2024
DIRECT CHARITABLE EXPENDITURE
(Amounts payable in furtherance
of the Charities obj ects):
Clinical unit grants
Complimentary medicine grants
Chemotherapy pool car grant
90,245
3,180
90,245
3,180
19,259
5,484
93,425
93,425
24,743
T'he above grnnts were made in support of Musgrove Park Hospital in Taunton.
FUND RAISIIYG AND PUBLICITY
Fund raising costs
Publications
480
201
480
201
209
681
681
209

MUSGROVL L￿1 UKAEMIC GROUP SOMERSET
Raising funds for the benefit of Patients in Somerset
NOTEI S TO THE ACCOUNTS
FOR THE YEAR ￿ND￿D 28 FEBRUARY 2025
(Continued)
Unrestricted Restricted Total Funds Total Funds
Funds
Funds
2025
2024
MANAGEMENT AND
ADMINISTRATION OF CHARITY
Public liability insurance
Independent examiners fees
Letterhead paper
580
480
30
580
480
30
566
420
1,090
1,090
986
DEBTORS
Income tax recoverable
623
722
CRfi DITORS: Amounts falling due within one year
Accountancy accrual
Clinical unit grants accrual
450
43,665
420
44,115
420
Balance Net movement Balance
1.3.24
funds
28.2.25
UNRESTRICTED FUNDS
General Fund
911,269
(40,587) 870,682
14